StockData
Annexon, Inc. logo

Annexon, Inc. (ANNX) stock

ANNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$3.52+0.05 (+1.44%)

Close on Nov 18, 2026Market cap $719.65MP/E –Yield 0.00%

Annexon net income

Net income is the profit left for shareholders after every expense, interest and tax.

Annexon's net income for the twelve months ending Jun 30, 2026 was -$202.67M. For fiscal 2025 it was -$206.69M. The highest annual figure on record is -$37.18M in fiscal 2019.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$206.69M–
FY2024Dec 31, 2024-$138.20M–
FY2023Dec 31, 2023-$134.24M–
FY2022Dec 31, 2022-$141.95M–
FY2021Dec 31, 2021-$130.32M–
FY2020Dec 31, 2020-$63.41M–
FY2019Dec 31, 2019-$37.18M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$55.35M–
Q1 FY2026Mar 31, 2026-$44.14M–
Q4 FY2025Dec 31, 2025-$48.26M–
Q3 FY2025Sep 30, 2025-$54.92M–
Q2 FY2025Jun 30, 2025-$49.16M–
Q1 FY2025Mar 31, 2025-$54.36M–
Q4 FY2024Dec 31, 2024-$48.59M–
Q3 FY2024Sep 30, 2024-$34.82M–
Q2 FY2024Jun 30, 2024-$29.61M–
Q1 FY2024Mar 31, 2024-$25.18M–
Q4 FY2023Dec 31, 2023-$27.89M–
Q3 FY2023Sep 30, 2023-$32.48M–
Q2 FY2023Jun 30, 2023-$35.19M–
Q1 FY2023Mar 31, 2023-$38.68M–
Q4 FY2022Dec 31, 2022-$34.38M–
Q3 FY2022Sep 30, 2022-$35.05M–
Q2 FY2022Jun 30, 2022-$37.14M–
Q1 FY2022Mar 31, 2022-$35.37M–
Q4 FY2021Dec 31, 2021-$37.37M–
Q3 FY2021Sep 30, 2021-$35.60M–
Q2 FY2021Jun 30, 2021-$31.29M–
Q1 FY2021Mar 31, 2021-$26.06M–
Q4 FY2020Dec 31, 2020-$23.19M–
Q3 FY2020Sep 30, 2020-$15.64M–
Q2 FY2020Jun 30, 2020-$12.24M–
Q1 FY2020Mar 31, 2020-$12.34M–
Q4 FY2019Dec 31, 2019-$8.94M–
Q3 FY2019Sep 30, 2019-$10.19M–
Q2 FY2019Jun 30, 2019-$9.40M–
Q1 FY2019Mar 31, 2019-$8.65M–

More Annexon figures

See a number that looks wrong?